Spectrum Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
SPPI Spectrum Pharmaceuticals Inc
FDBC Fidelity D&D Bancorp Inc
$BUKCHET Bloomberg Coffee Subindex Euro
BMY Bristol-Myers Squibb Co
MLGO MicroAlgo Inc
FRST Primis Financial Corp
VII 7GC & Holdings Co Inc
PEBO Peoples Bancorp Inc
BIOAF Bioasis Technologies Inc
NRGOF Newrange Gold Corp
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Value
Company profile

Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing, and commercializing targeted oncology therapies. The Company's product portfolio consists of in-development drug products for the treatment of cancer patients. The Company's pipeline products include Eflapegrastim and Poziotinib. The Eflapegrastim is a long-acting granulocyte colony-stimulating factor (G-CSF) for chemotherapy-induced neutropenia. Poziotinib is a, pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR) family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations. The Eflapegrastim employs a LAPSCOVERY technology to enhance the duration of therapeutic effects and reduce the frequency of administration.

Closing Price
$0.8198
Day's Change
0.0098 (1.21%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.83
Day's Low
0.7988
Volume
(Light)
Volume:
1,129,883

10-day average volume:
2,318,281
1,129,883

Omnicom Group Inc. Stock Outperforms Market On Strong Trading Day

5:25 pm ET December 1, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Omnicom Group Inc. (OMC) inched 0.13% higher to $79.86 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.09% to 4,076.57 and Dow Jones Industrial Average falling 0.56% to 34,395.01. This was the stock's third consecutive day of gains. Omnicom Group Inc. closed $11.75 below its 52-week high ($91.61), which the company reached on February 10th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Trade Desk Inc. Cl A (TTD) fell 0.44% to $51.91 and Gartner Inc. (IT) rose 1.68% to $356.27. Trading volume (1.6 M) eclipsed its 50-day average volume of 1.5 M.

Data source: Dow Jones Market Data, FactSet. Data compiled December 1, 2022.

	

(END) Dow Jones Newswires

December 01, 2022 17:25 ET (22:25 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.